Alumis (ALMS) Stock

NASDAQ / Healthcare / Biotechnology

$6.03

+3.08% Close Nov 6

ALMS stock daily candlestick chart with 50, 150 and 200-day moving averagesOpen interactive chart
One year of daily prices through the Nov 6, 2026 close. This page updates by about 4 AM ET after each trading day. The interactive chart has the full history.

ALMS stock price and performance

ALMS stock closed at $6.03 on Nov 6, 2026. The tables below use that final daily session.

Last close
$6.03
Day range
$5.82 to $6.08
52-week range
$4.40 to $31.35
From 52-week high
−80.8%
Average volume (50 days)
3.3M
1 week
−10.4%
1 month
−13.5%
3 months
−78.1%
Year to date
−38.2%
1 year
+32.0%
3 years
–
5 years
–

Is ALMS stock in an uptrend?

No, ALMS stock is in a downtrend: it does not meet the Minervini Trend Template criteria and neither Daily Pivot Breakout momentum filter is active. Price is below its 200-day moving average.

Daily Pivot momentum filters
0 of 2 active
100-day ROC
−73.0% filter at 40%: off
100-day EMA slope
−36.2% filter at 25%: off
Trend state
Downtrend
Minervini Trend Template
Not met on the latest scan
50-day average
Below
150-day average
Below
200-day average
Below
200-day slope (1 month)
−5.01%
ATR (14) % of price
7.37%

Momentum filters from the Daily Pivot Breakout indicator: 100-day rate of change and 100-day EMA slope, each against its minimum.

Is ALMS stock in a Stage 2 uptrend?

No, ALMS stock is in a Stage 4 decline by our Weinstein stage analysis: its price is below a falling 30-week moving average.

Weinstein stage
Stage 4 (declining)
30-week SMA
$19.08
30-week slope (4 weeks)
−10.98%
Mansfield RS vs SPY
-69.43

Weinstein stage analysis uses weekly closes against the 30-week moving average and Mansfield relative strength versus SPY. See the free Stage 2 stocks screener.

ALMS support and resistance levels

LevelPriceFrom close
200-day SMA$20.94+247.3%
150-day SMA$19.19+218.3%
30-week SMA$19.08+216.4%
50-day SMA$8.13+34.8%
Daily Pivot resistance (pivot high)$7.25+20.2%
21-day EMA$6.81+13.0%
9-day EMA$6.39+5.9%
Latest Daily Pivot low$6.01−0.3%

Levels above the close act as resistance, levels below as support. Last close $6.03.

ALMS breakout and scanner signals

ScannerLast signal (free view, 5 sessions late)Past year
VCPFeb 18, 20264
RSI DivergenceSep 25, 20263
Weinstein Stage AnalysisAug 17, 2026157
Daily Pivot BreakoutJun 29, 20264
Minervini Trend TemplateAug 10, 202693
Episodic PivotJan 6, 20261
Ichimoku TK crossAug 3, 2026 (bearish)8
9/21 EMA crossAug 11, 2026 (bearish)7
Golden / Death CrossSep 18, 2026 (bearish)2
RS RatingAug 31, 2026171

ALMS earnings history

ReportedEPS estimateEPS actualSurprise
Aug 13, 2026$-0.71$-0.79−11.3%
May 14, 2026$-0.77$-0.74+3.9%
Mar 31, 2026$0.59$0.66+11.9%
Mar 19, 2026$-0.98$-0.25+74.5%

ALMS bull and bear case

What looks strong

  • No strong points in the trend data on the latest scan.

What looks weak

  • Neither Daily Pivot momentum filter is active (100-day ROC -73.0%, 100-day EMA slope -36.2%; the filters need 40% and 25%).
  • Does not meet the Minervini Trend Template on the latest scan.
  • Price is below the 200-day moving average, which is falling.
  • Short interest is 14.27% of shares outstanding.
  • Net income over the last 12 months is negative.

Drawn only from the data on this page. Not a recommendation.

ALMS news and SEC filings, last 30 days

Source: SEC EDGAR.

ALMS insider trading and risks

Buys, last 90 days
0 ($0)
Sales, last 90 days
6 ($23,622)
Buys, last 12 months
0 ($0)
Sales, last 12 months
6 ($23,622)
DateInsiderTradeValue
Nov 2Schroer John R.Chief Financial OfficerSale 794 shares$5,177
Nov 2Hardiman Roy C.Chief Business & Strategy OfcrSale 652 shares$4,251
Nov 2Goldstein David MChief Scientific OfficerSale 629 shares$4,101
Nov 2Bradley Mark ChristopherChief Development OfficerSale 623 shares$4,062
Nov 2Drappa JornChief Medical OfficerSale 593 shares$3,866

Risk flags from the data

  • Short interest is 14.27% of shares outstanding.
  • Net income over the last 12 months is negative.

Insider trades: SEC Form 4 open-market purchases and sales.

ALMS valuation and fundamentals

Market cap
$780.5M
Enterprise value
$291.3M
P/E (trailing)
0.2
P/E (forward)
-2.1
PEG
0.00
Price to sales
105.50
Price to book
1.71
EV to EBITDA
-0.7
Gross margin
–
Operating margin
−6,439.9%
Profit margin
0.0%
Return on equity
−93.6%
Revenue (TTM)
$7.4M
Revenue growth (quarter, y/y)
−37.7%
Cash
$502.3M
Debt
$36.4M
Beta
-0.27
Fiscal yearRevenueNet incomeFree cash flow
2025$24.1M−$243.3M−$369.5M
2024$0−$294.2M−$266.6M
2023$0−$155.0M−$148.4M
2022$0−$111.9M−$106.7M

ALMS dividends and splits

Dividend yield
0.00%

Who owns ALMS?

Shares outstanding
128.5M
Float
91.3M
Held by insiders
+0.5%
Held by institutions
+94.3%
Short interest (% of shares)
+14.3%
Days to cover
4.2

What does Alumis Inc. do?

CEO
Mr. Martin Babler Ph.D.
Employees
237
Headquarters
South San Francisco, CA, United States
Website
alumis.com

Updated Nov 6, 2026. Prices and fundamentals: Source: Twelve Data. Filings and insider trades: SEC EDGAR. Charts: TradingView Lightweight Charts. Educational information, not investment advice.